Baden-Württemberg is Germany’s largest pharma location. In addition to industry giants such as Roche, GlaxoSmithKline and Boehringer Ingelheim, Baden-Württemberg is home to a large number of small- and medium-sized pharmaceutical companies and biotech companies with pharmaceutical R&D. According to the Baden-Württemberg Statistics Office, one in four employees in the pharmaceutical industry work in Baden-Württemberg.
The pharmaceutical industry continues to be a recession-proof employer and is very loyal to Baden-Württemberg. According to BIOPRO 126 pharmaceutical companies are located in Baden-Württemberg. Of them, 46 companies are pure distributors, suppliers or plant manufacturers. 86 of the 126 pharmaceutical companies carry out research, development and/or manufacture in Baden-Württemberg. The Baden-Württemberg Statistics Office has been able to acquire key figures for 2016 for 83 out of the 86 companies:
Most pharmaceutical companies are located in the southern Upper Rhine region (15) and the central Upper Rhine and Hochrhein-Bodensee regions (14 each).
Danube-Iller and Rhine-Neckar are the two regions with the highest revenues. Companies in the Donau-Iller region generated 28% of overall revenues and companies in the Rhine-Neckar region, 18%.